Nicole Junkermann invests in Owkin UK, founded in 2016, alongside Brent Hoberman and they are passionate about the healthcare sector and its growing use of biotech.
Nicole Junkermann, founder of NJF Holdings, is an entrepreneur turned private investor currently based in London.
Owkin is a ground-breaking biotech company, using technology to accelerate medical research and connect pharms to hospitals to reveal medical insights.
NJF Holdings seeks to work with visionaries like Brent Hoberman who seek to breakdown established approaches in investment sectors.
London has proved a strong and secure base for Nicole Junkermann and NJF Holdings to explore further venture start-up opportunities in biotech.